Regulatory Headwinds Rattle Tilray Shares
Published on 11/13/2025 at 06:57 | Redaktion boerse-global.de
Tilray shares experienced significant downward pressure on Tuesday, declining 5.4 percent to close at $1.22. The cannabis company’s vocal opposition to newly proposed U.S. hemp restrictions within a government funding bill created uncertainty among investors, triggering the sell-off.
The market reaction comes despite Tilray’s recently reported strong operational performance. Just in October, the company announced record quarterly revenue reaching $209.5 million, alongside net income of $1.5 million. Its adjusted EBITDA showed a 9 percent improvement, climbing to $10 million.
Trading volume surged to 34.67 million shares during the session, indicating substantial investor anxiety about the regulatory developments. This contrasts sharply with the stock’s recent peak of $2.32 reached on October 9, from which Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
